Extracellular vesicles (EVs) are gaining ground as next-generation drug delivery modalities.
Genetic fusion of the protein of interest to a scaffold protein with high EV-sorting ability …

Gene editing technologies have the potential to correct genetic disorders by modifying,
inserting, or deleting specific DNA sequences or genes, paving the way for a new class of …

Extracellular vesicles, particularly exosomes, have emerged as promising drug delivery
systems owing to their unique advantages, such as biocompatibility, immune tolerability, and …

From their humble discovery as cellular debris to cementing their natural capacity to transfer
functional molecules between cells, the long-winded journey of extracellular vesicles (EVs) …

Extracellular vesicles (EVs) have important roles as mediators of cell-to-cell communication,
with physiological functions demonstrated in various in vivo models. Despite advances in …

Messenger RNA (mRNA) has emerged as an attractive therapeutic molecule for a range of
clinical applications. For in vivo functionality, mRNA therapeutics require encapsulation into …

Extracellular vesicles (EVs) hold great promise as therapeutic delivery vehicles, although
their potential is limited by a lack of efficient EV engineering strategies to enhance loading …

Extracellular vesicles (EVs) are gaining ground as next-generation drug delivery modalities.
Genetic fusion of the protein of interest to a scaffold protein with high EV-sorting ability …